Sample Size Re-estimation Design in Phase II Dose Finding Study with Multiple Dose Groups: Frequentist and Bayesian Methods

12/29/2020
by   Qingyang Liu, et al.
0

Unblinded sample size re-estimation (SSR) is often planned in a clinical trial when there is large uncertainty about the true treatment effect. For Proof-of Concept (PoC) in a Phase II dose finding study, contrast test can be adopted to leverage information from all treatment groups. In this article, we propose two-stage SSR designs using frequentist conditional power and Bayesian posterior predictive power for both single and multiple contrast tests. The Bayesian SSR can be implemented under a wide range of prior settings to incorporate different prior knowledge. Taking the adaptivity into account, all type I errors of final analysis in this paper are rigorously protected. Simulation studies are carried out to demonstrate the advantages of unblinded SSR in multi-arm trials.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
03/11/2021

BaySize: Bayesian Sample Size Planning for Phase I Dose-Finding Trials

We propose BaySize, a sample size calculator for phase I clinical trials...
research
04/12/2023

A Multi-Arm Two-Stage (MATS) Design for Proof-of-Concept and Dose Optimization in Early-Phase Oncology Trials

The Project Optimus initiative by the FDA's Oncology Center of Excellenc...
research
02/20/2021

Adaptive dose-response studies to establish proof-of-concept in learning-phase clinical trials

In learning-phase clinical trials in drug development, adaptive designs ...
research
11/03/2021

Incorporating Surrogate Information for Adaptive Subgroup Enrichment Design with Sample Size Re-estimation

Adaptive subgroup enrichment design is an efficient design framework tha...
research
11/24/2018

A multiple comparison procedure for dose-finding trials with subpopulations

Identifying subgroups of patients with an enhanced response to a new tre...
research
12/01/2022

Bayesian Framework for Multi-Source Data Integration – Application to Human Extrapolation From Preclinical Studies

In preclinical investigations, e.g. in in vitro, in vivo and in silico s...
research
07/03/2019

A Bayesian decision-theoretic approach to incorporate preclinical information into phase I oncology trials

Leveraging preclinical animal data for a phase I first-in-man trial is a...

Please sign up or login with your details

Forgot password? Click here to reset